Updated on Jun 30, 2022 | Inside, Research
A unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders, such as sickle cell anemia, is being readied for clinical trials at the Icahn School of Medicine at Mount Sinai, with an $8.8 million grant from the New York State Stem Cell Science Program (NYSTEM).
The stem cells—also known as hematopoietic stem cells—are derived from the vein of the umbilical cord and help renew and replenish blood cells. They represent the only potential therapy for blood cancer patients who do not respond to chemotherapy. The new method is necessary to compensate for the limited number of stem cells that are typically found in blood cord collections and the fact that using stem cells from two or more blood cord collections is generally not a viable option because the blood cells are not identical. (more…)
Updated on Jun 30, 2022 | Inside, Your Health
Sean P. Pinney, MD, was recently named the first Director of Heart Failure and Transplantation for the Mount Sinai Health System. He will also continue to serve as Director of Advanced Heart Failure and Transplantation at The Mount Sinai Hospital and Associate Professor of Medicine (Cardiology) at Icahn School of Medicine at Mount Sinai, where he has led a number of clinical trials in heart failure, cardiac transplantation, and mechanical circulatory support. (more…)
Updated on Jun 30, 2022 | Inside, Research, Your Health
Mount Sinai scientists and clinicians are making notable advances in the study and treatment of heart failure, a common condition that occurs when the heart becomes too weak to pump and circulate enough blood through the body. Diseases that damage the heart—such as coronary artery disease, high blood pressure, and diabetes—can lead to heart failure, which develops over time as the heart’s pumping action grows weaker. It impacts an estimated 5 million adults and children in this country. (more…)
Updated on Jun 30, 2022 | Inside, Your Health
The Mount Sinai Transplant Living Center, which provides convenient and affordable overnight accommodations to patients and their families receiving care at the Recanati/Miller Transplantation Institute (RMTI), has undergone a full renovation, featuring new kitchens, bathrooms, and furniture.
The renovation was a generous gift from benefactors Ken and Meryl Sherman who were looking to give back to RMTI on the fourteenth anniversary of Mrs. Sherman’s successful kidney transplant, for which Mr. Sherman was the donor. (more…)
Updated on Jun 30, 2022 | Inside, School
Before a capacity audience in Stern Auditorium that included faculty, staff, students, and the public, Atul Gawande, MD, MPH, noted surgeon, writer, and public health researcher, recently presented a professional overview—yet highly personalized account—of modern medicine’s impact on how we age, and die, in the twenty-first century. His speech, titled “Being Mortal,” based on his book, Being Mortal: Medicine and What Matters in the End, was delivered as the 2015 Annual Douglas West Memorial Lecture, an event sponsored by Mount Sinai’s Lilian and Benjamin Hertzberg Palliative Care Institute. (more…)
Jul 9, 2015 | Inside, Your Health
Mount Sinai Queens Community Health Fair Draws 900 Attendees
Mount Sinai Queens and the United Community Civic Association co-hosted a daylong neighborhood health fair at Kaufman Astoria Studios on Saturday, June 6, attracting some 900 attendees. Mount Sinai Queens staff offered a wide range of free health screenings, including glucose, cholesterol, blood pressure, asthma, and osteoporosis. They also measured body mass index and provided information on weight control, stress management, and smoking cessation and prevention. Attendees enjoyed free, healthy snacks from the hospital chef, family fun activities, and entertainment. (more…)
A unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders, such as sickle cell anemia, is being readied for clinical trials at the Icahn School of Medicine at Mount Sinai, with an $8.8 million grant from the New York State Stem Cell Science Program (NYSTEM).
